Chelsea Therapeutics International Ltd. (CHTP) Key Ratios

Profile for Chelsea Therapeutics International Ltd.  (CHTP) 
$ 4.99   0.01 (+0.20%) Volume: 572.82 k 4:00 PM EST Feb 10, 2012
After Hours:  $ 5.09   0.10 (+2.00%) Volume: 200  5:45 PM EST Feb 10, 2012
Income Statements
Revenue (LTM) ($):
Revenue per Share (LTM) ($): 0.00
Revenue per Employee (LTM) ($): 0.00
Revenue Growth 3 Yr: N/A
Revenue Growth 5 Yr: N/A
 
Dividends & Splits
Annual Dividend Rate ($): N/A
Annual Dividend Yield: N/A
Dividend Growth 3 Yr: N/A
Dividend Growth 5 Yr: N/A
Ex-Dividend Date: N/A
Payment Type: N/A
Financial Strength (LTM)
Quick Ratio: 4.20
Current Ratio: 4.30
Long Term Debt to Total Capital: N/A
Total Debt to Equity: N/A
Interest Coverage: N/A
Leverage Ratio: 1.30
 
Profitability (LTM)
Gross Margin: N/A
EBIT Margin: N/A
EBITDA Margin: N/A
Pre-Tax Profit Margin: N/A
Profit Margin (Cont. Op): N/A
Profit Margin (Total Op): N/A
Management Effectiveness LTM 5 Yr Avg
Return on Equity N/A N/A
Return on Capital -80.20% -80.20%
Return on Assets -59.10% -59.10%
 
Assets
Asset Turnover: N/A
Inventory Turnover: N/A
Receivable Turnover: N/A
Valuation Measures
P/E Ratio: N/A
P/E High - Last 5 Years: N/A
P/E Avg. High - Last 5 Years: N/A
P/E Low - Last 5 Years: N/A
P/E Avg. Low - Last 5 Years: N/A
 
Price to Sales: 
Price to Book: 7.37
Price to Tangible Book: 7.37
Price to Cash Flow: -6.70
Price to Free Cash: -7.50